Temomedac 5 mg hard capsules
Each hard capsule contains 5 mg temozolomide.
Temomedac hard capsules is indicated for the treatment of:
- adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment.
- children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
Pack sizes:
N5, N20
N5, N20
